Pharmacy News

2013 NCPA Awards Forms

2013 Independent Pharmacist of the Year

2013 Prescription Drug Safety Award

2012 Fungal Meningitis Outbreak

One-Sheet explanation of proposed Federal Legislation in response to outbreak.

CDC HAN 00333 Contamination identified in additional medical products from NECC.

Health Advisory from Kentucky Department of Health, 10/29/2012
For more information on this advisory, or to report cases, contact Dr. Terry Bunn tlbunn2@uky.edu 859-257-4955

CDC & FDA release 10/4/2012

Kentucky Release 10/8/2012

FDA Alert 10/15/2012

FDA issued an  updated MedWatch Safety alert on the ongoing meningitis outbreak associated with the injection of products distributed by New England Compounding Pharmacy (NECC). The alert includes a complete list of the medications recalled. In the FDA statement, two new suspect products are identified (triamcinolone acetonide and cardioplegic solution). FDA is also updating the recommendations for actions by health care professionals and patients. The FDA is especially interested in notifying members of FDA’s interest in receiving adverse event reports, through theFDA Medwatch online reporting system, if you suspect that the use of an NECC injectable product is associated with a serious infection.

Helpful links:

http://emergency.cdc.gov/HAN/han00329.asp

http://www.cdc.gov/hai/outbreaks/clinicians/guidance_cns.html 

Preliminary Report on Investigation